BRENDA PURSLEY: Open Payments
NPI 1316926991 · COFFEYVILLE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 25 payments from 11 companies in 2025. Trend: 2023 $294 · 2024 $353 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| PFIZER INC. | 2 | $59 |
| Novo Nordisk Inc | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| ABBVIE INC. | 2 | $28 |
| Boston Scientific Corporation | 1 | $24 |
| Amgen Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: AIRSUPRA, CAPLYTA, PREVNAR 20, FARXIGA, Kerendia, VAXNEUVANCE, Wegovy, WATCHMAN Access System.
Industry payments across KS — which companies pay providers there.
